UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 19, 2020 5:30 P.M.
Form:
S-4
CIK:
0001566373
Company Name:
Spring Bank Pharmaceuticals, Inc.
File Number:
333-248487